Cooley, Jingtian & Gongcheng and King & Wood Mallesons advised YZY Biopharma, while Sidley and Merits & Tree acted as legal counsel for the sole sponsor...
Wuhan YZY Biopharma’s HK$176 Million Initial Public Offering
Fenbi’s HK$198 Million Listing on The HKSE
Cooley advised the underwriters involved in the listing while Wilson Sonsini Goodrich & Rosati represented Fenbi. Fenbi, an internet-born test preparation company, proposed the listing of...
China Bright Culture Group’s HK$904 Million Initial Public Offering
Sidley Austin and Tian Yuan advised China Bright Culture Group, while Wilson Sonsini Goodrich & Rosati represented joint sponsors, Haitong International Capital Limited and BOCOM International...